CSF-1R-ANTIKÖRPERFORMULIERUNG

Patent europeic · EP3849518 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3849518
Numer da la dumonda
EP19765736
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
12-09-2019
Publitgà
21-07-2021
Concedì
18-03-2026
La protecziun finescha il pli tard
11-09-2039
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
A61K 9/08 (2006.01)
A61K 9/19 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
A61P 19/02 (2006.01)
C07K 16/28 (2006.01)
A61K 45/06 (2006.01)
A61K 47/26 (2006.01)
Prioritad
EP 18194145 13.09.2018
Dumonda PCT
PCT/EP2019/074303 12.09.2019
Publicaziun PCT
WO2020/053321 19.03.2020
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 24-06-2026

    Owner

    Owner
    F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel → F. Hoffmann-La Roche AG, Grenzacherstraße 124, 4070 Basel

    Published in Swissreg on 24.06.2026

  3. 18-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 18.03.2026

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.